<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article
  PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "http://dtd.nlm.nih.gov/publishing/3.0/journalpublishing3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="3.0" xml:lang="en">
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">PLoS ONE</journal-id>
<journal-id journal-id-type="publisher-id">plos</journal-id>
<journal-id journal-id-type="pmc">plosone</journal-id>
<journal-title-group>
<journal-title>PLOS ONE</journal-title>
</journal-title-group>
<issn pub-type="epub">1932-6203</issn>
<publisher>
<publisher-name>Public Library of Science</publisher-name>
<publisher-loc>San Francisco, CA USA</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.1371/journal.pone.0134088</article-id>
<article-id pub-id-type="publisher-id">PONE-D-14-55524</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Research Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Gout and Risk of Myocardial Infarction: A Systematic Review and Meta-Analysis of Cohort Studies</article-title>
<alt-title alt-title-type="running-head">Gout and Risk of Myocardial Infarction</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" equal-contrib="yes" xlink:type="simple">
<name name-style="western">
<surname>Liu</surname>
<given-names>Shuang-Chun</given-names>
</name>
<xref rid="aff001" ref-type="aff"><sup>1</sup></xref>
</contrib>
<contrib contrib-type="author" equal-contrib="yes" xlink:type="simple">
<name name-style="western">
<surname>Xia</surname>
<given-names>Lei</given-names>
</name>
<xref rid="aff002" ref-type="aff"><sup>2</sup></xref>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<name name-style="western">
<surname>Zhang</surname>
<given-names>Jin</given-names>
</name>
<xref rid="aff001" ref-type="aff"><sup>1</sup></xref>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<name name-style="western">
<surname>Lu</surname>
<given-names>Xue-Hong</given-names>
</name>
<xref rid="aff003" ref-type="aff"><sup>3</sup></xref>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<name name-style="western">
<surname>Hu</surname>
<given-names>Da-Kang</given-names>
</name>
<xref rid="aff001" ref-type="aff"><sup>1</sup></xref>
</contrib>
<contrib contrib-type="author" corresp="yes" xlink:type="simple">
<name name-style="western">
<surname>Zhang</surname>
<given-names>Hai-Tao</given-names>
</name>
<xref rid="aff004" ref-type="aff"><sup>4</sup></xref>
<xref rid="econtrib001" ref-type="fn"><sup>‡</sup></xref>
<xref rid="cor001" ref-type="corresp">*</xref>
</contrib>
<contrib contrib-type="author" corresp="yes" xlink:type="simple">
<name name-style="western">
<surname>Li</surname>
<given-names>Hai-Jun</given-names>
</name>
<xref rid="aff005" ref-type="aff"><sup>5</sup></xref>
<xref rid="econtrib001" ref-type="fn"><sup>‡</sup></xref>
<xref rid="cor001" ref-type="corresp">*</xref>
</contrib>
</contrib-group>
<aff id="aff001"><label>1</label> <addr-line>Department of Clinical Laboratory, Taizhou Municipal Hospital, Taizhou, Zhejiang, China</addr-line></aff>
<aff id="aff002"><label>2</label> <addr-line>Department of Urinary Surgery, Affiliated Renji Hospital, Medical School of Shanghai Jiao Tong University, Shanghai, China</addr-line></aff>
<aff id="aff003"><label>3</label> <addr-line>Department of Pediatrics, Taizhou Municipal Hospital, Taizhou, Zhejiang, China</addr-line></aff>
<aff id="aff004"><label>4</label> <addr-line>Department of Urinary Surgery, Taizhou Municipal Hospital,Taizhou, Zhejiang, China</addr-line></aff>
<aff id="aff005"><label>5</label> <addr-line>Department of Neurology, Taizhou Municipal Hospital, Taizhou, Zhejiang, China</addr-line></aff>
<contrib-group>
<contrib contrib-type="editor" xlink:type="simple">
<name name-style="western">
<surname>Pizzi</surname>
<given-names>Carmine</given-names>
</name>
<role>Editor</role>
<xref ref-type="aff" rid="edit1"/>
</contrib>
</contrib-group>
<aff id="edit1"><addr-line>University of Bologna, ITALY</addr-line></aff>
<author-notes>
<fn fn-type="conflict" id="coi001">
<p>The authors have declared that no competing interests exist.</p>
</fn>
<fn fn-type="con" id="contrib001">
<p>Conceived and designed the experiments: SCL LX JZ XHL DKH HTZ HJL. Performed the experiments: SCL LX JZ XHL DKH. Analyzed the data: SCL LX JZ XHL. Contributed reagents/materials/analysis tools: SCL LX JZ XHL DKH. Wrote the paper: SCL LX DKH.</p>
</fn>
<fn fn-type="other" id="econtrib001">
<p>‡ These authors also contributed equally to this work.</p>
</fn>
<corresp id="cor001">* E-mail: <email xlink:type="simple">tzzhanghaitao@hotmail.com</email> (HTZ); <email xlink:type="simple">lhjyy@126.com</email> (HJL)</corresp>
</author-notes>
<pub-date pub-type="epub">
<day>31</day>
<month>7</month>
<year>2015</year>
</pub-date>
<pub-date pub-type="collection">
<year>2015</year>
</pub-date>
<volume>10</volume>
<issue>7</issue>
<elocation-id>e0134088</elocation-id>
<history>
<date date-type="received">
<day>16</day>
<month>1</month>
<year>2015</year>
</date>
<date date-type="accepted">
<day>6</day>
<month>7</month>
<year>2015</year>
</date>
</history>
<permissions>
<copyright-year>2015</copyright-year>
<copyright-holder>Liu et al</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/" xlink:type="simple">
<license-p>This is an open access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/" xlink:type="simple">Creative Commons Attribution License</ext-link>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited</license-p>
</license>
</permissions>
<self-uri content-type="pdf" xlink:href="info:doi/10.1371/journal.pone.0134088" xlink:type="simple"/>
<abstract>
<sec id="sec001">
<title>Introduction</title>
<p>A high incidence of myocardial infarction among patients with gout has been suggested by several observational studies. We performed a meta-analysis to evaluate the association between gout and the risk of myocardial infarction.</p>
</sec>
<sec id="sec002">
<title>Materials and Methods</title>
<p>The PubMed and Embase databases were searched from inception to October 2014 for cohort studies that evaluating the association between gout and the risk of myocardial infarction. Summary estimates were derived using a random-effects model and reported as relative risks (RRs) with 95% confidence intervals (CIs).</p>
</sec>
<sec id="sec003">
<title>Results</title>
<p>Five studies involving 8,656,413 participants with a total of 1000 MI events were included. Overall, gout was associated with an increased risk of myocardial infarction (RR 1.45; 95% CI, 1.19–1.75; <italic>p</italic>&lt;0.001), and the association referred to non-fatal myocardial infarction (RR 1.29; 95% CI, 1.19–1.39; <italic>p</italic> &lt;0.001) but not fatal myocardial infarction (RR 1.11; 95% CI, 0.96–1.28; <italic>p</italic> = 0.174). The increased risk was observed in both women (RR 1.62; 95% CI, 1.18–2.21; <italic>p</italic> = 0.003) and men (RR 1.45; 95% CI, 1.21–1.74; <italic>p</italic> &lt;0.001). Stratified analysis revealed a gradual increase in myocardial infarction risk with a younger age of gout onset (age 20–44 years old (RR 2.82; 95% CI, 1.38–5.79; <italic>p</italic> = 0.05); 45–69 years old (RR 1.85; 95% CI, 1.22–2.82; <italic>p</italic> = 0.04); ≥70 years old (RR 1.52; 95% CI, 1.22–1.88; <italic>p</italic> &lt;0.001)).</p>
</sec>
<sec id="sec004">
<title>Conclusion</title>
<p>This meta-analysis suggests that patients with gout have an increased risk of myocardial infarction.</p>
</sec>
</abstract>
<funding-group>
<funding-statement>The present study was supported by Medical Science and Technology Support of Zhejiang Province (2013ZHB015). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</funding-statement>
</funding-group>
<counts>
<fig-count count="5"/>
<table-count count="1"/>
<page-count count="13"/>
</counts>
<custom-meta-group>
<custom-meta id="data-availability" xlink:type="simple">
<meta-name>Data Availability</meta-name>
<meta-value>All relevant data are within the paper and its Supporting Information files.</meta-value>
</custom-meta>
</custom-meta-group>
</article-meta>
</front>
<body>
<sec id="sec005" sec-type="intro">
<title>Introduction</title>
<p>According to World Health Organization estimates, ischemic heart disease is the primary cause of death worldwide, accounting for 7.4 million fatalities [<xref rid="pone.0134088.ref001" ref-type="bibr">1</xref>,<xref rid="pone.0134088.ref002" ref-type="bibr">2</xref>]. Myocardial infarction (MI), which accounts for the majority of ischemic heart disease cases and affects approximately 1 US citizen per 44 seconds, is associated with undesirably high rates of morbidity and mortality; approximately 15% of MI cases are fatal [<xref rid="pone.0134088.ref003" ref-type="bibr">3</xref>,<xref rid="pone.0134088.ref004" ref-type="bibr">4</xref>]. Therefore, an exploration of MI risk factors for primary prevention should be a major public health priority.</p>
<p>Gout is the most prevalent form of inflammatory arthritis in developed countries, the prevalence of gout in clinical practices in the UK and Germany is 1.4%, and this disease is estimated to affect 0.9% and 3.9% adults in France and the USA respectively [<xref rid="pone.0134088.ref005" ref-type="bibr">5</xref>–<xref rid="pone.0134088.ref007" ref-type="bibr">7</xref>]. Epidemiologic studies have indicated that the incidence and prevalence of gout are increasing worldwide and that more people are at an increased risk of developing gout [<xref rid="pone.0134088.ref008" ref-type="bibr">8</xref>–<xref rid="pone.0134088.ref010" ref-type="bibr">10</xref>]. In gout patients, the inflammatory response associated with gout plays a key role in the initiation and progression of atherosclerosis, and promotion of a pro-thrombotic environment that leads to acute coronary events such as angina or MI [<xref rid="pone.0134088.ref011" ref-type="bibr">11</xref>,<xref rid="pone.0134088.ref012" ref-type="bibr">12</xref>]. To test this important hypothesis, a number of observational studies during the past decade have addressed the association between gout and the risk of MI [<xref rid="pone.0134088.ref013" ref-type="bibr">13</xref>–<xref rid="pone.0134088.ref019" ref-type="bibr">19</xref>]. However, no systematic reviews or data pooling for a definite conclusion have been attempted; we therefore performed a meta-analysis of cohort studies to evaluate the risk of MI among patients with gout versus those without gout.</p>
</sec>
<sec id="sec006" sec-type="materials|methods">
<title>Materials and Methods</title>
<sec id="sec007">
<title>Literature search</title>
<p>We adopted the Meta-analysis Of Observational Studies in Epidemiology (MOOSE) checklist when reporting this review [<xref rid="pone.0134088.ref020" ref-type="bibr">20</xref>]. We systematically searched the PubMed and Embase databases (from inception to October 2014) for studies investigating the association between gout and myocardial infarction. No language restrictions were imposed. Search terms included ‘gout’ and ‘myocardial infarction’. Furthermore, the reference lists of identified manuscripts were hand-searched and scrutinized to identify other relevant publications.</p>
</sec>
<sec id="sec008">
<title>Selection criteria</title>
<p>We applied the following inclusion criteria when selecting eligible studies: (i) cohort study; (ii) examination of the association between gout and the risk of MI; (iii) reported the effect size data such as odds ratios (ORs), hazard ratios (HRs) or relative risks (RRs) with 95% confidence intervals (CIs) or provided data allowing the calculation of these values.</p>
</sec>
<sec id="sec009">
<title>Data extraction</title>
<p>The following information were extracted from each included study: first author, publication year, country, population characteristics, cohort size, number of gout cases, number of MI events, follow-up duration, ascertainment of gout, assessment of MI, and adjusted covariates. Supplementary files were also examined for data abstraction. When necessary, we contacted the authors of included articles for additional data. Extracted data were entered into a standardized Excel (Microsoft Corporation, Redmond, WA, USA) file. Data extraction was performed independently by two authors (SCL and LX). Any disagreement was resolved by discussion and consensus.</p>
</sec>
<sec id="sec010">
<title>Assessment of study quality</title>
<p>The Newcastle–Ottawa Scale (NOS) was used to assess the quality of each included study [<xref rid="pone.0134088.ref021" ref-type="bibr">21</xref>]. The quality of cohort studies was evaluated according to the following three major components: selection of the study group (0–4 points); quality of the confounding adjustment (0–2 points); and assessment of cohort outcomes (0–3 points). A higher NOS score indicates better methodological quality, as well as a lower risk of bias.</p>
</sec>
<sec id="sec011">
<title>Statistical analysis</title>
<p>We used RR as the common measure of an association between gout and the risk of MI. We conducted additional analyses to evaluate the risks of fatal MI and non-fatal MI, as well as the risks in both women and men. Furthermore, we performed stratified analyses to evaluate differences in risk between age groups (20–44 years versus 45–69 years versus ≥70 years). Heterogeneity was assessed using the Cochran Q statistic (<italic>p</italic> &lt;0.1) and measured with the <italic>I</italic><sup><italic>2</italic></sup> statistic, which was used to estimate the percentage of effect size variability that is attributable to heterogeneity across studies [<xref rid="pone.0134088.ref022" ref-type="bibr">22</xref>–<xref rid="pone.0134088.ref024" ref-type="bibr">24</xref>]. <italic>I²</italic> values of 25%, 50%, and 75% were used as cut-off points for low, moderate, and significant degrees of heterogeneity respectively. A random-effects model was used regardless of heterogeneity. A <italic>p</italic> value &lt;0.05 was considered statistically significant, unless where otherwise specified. We used STATA, version 12.0 (Stata Corporation, College Station, TX, USA) to perform the statistical analysis.</p>
</sec>
</sec>
<sec id="sec012" sec-type="results">
<title>Results</title>
<sec id="sec013">
<title>Description of the studies</title>
<p>A detailed flowchart of the search and selection results is shown in <xref rid="pone.0134088.g001" ref-type="fig">Fig 1</xref>. The initial search identified a total of 357 potentially relevant records through electronic searching, and five additional records identified through other sources. Eighty-one records were excluded as duplicates, 267 were identified as irrelevant after reading the titles and abstracts, and the remaining 14 full-text articles were eligible for further assessment. After the inclusion criteria were applied, five studies with a total of 8,656,413 participants were included in the meta-analysis [<xref rid="pone.0134088.ref013" ref-type="bibr">13</xref>–<xref rid="pone.0134088.ref017" ref-type="bibr">17</xref>].</p>
<fig id="pone.0134088.g001" position="float">
<object-id pub-id-type="doi">10.1371/journal.pone.0134088.g001</object-id>
<label>Fig 1</label>
<caption>
<title>Flow diagram for selection of articles.</title>
</caption>
<graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0134088.g001" position="float" xlink:type="simple"/>
</fig>
<p><xref rid="pone.0134088.t001" ref-type="table">Table 1</xref> shows the major characteristics of the five eligible cohort studies (additional details have been provided in <xref rid="pone.0134088.s002" ref-type="supplementary-material">S1 Table</xref>.), which were published between 2006 and 2013. Two studies were conducted in Canada, and one study each was conducted in the USA, UK, and China. The numbers of participants in each study ranged from 1,175 to 7,357,019 and the mean follow-ups ranged from 3.8 to 12 years. Study-specific quality assessments scores for the five articles are summarized in <xref rid="pone.0134088.s003" ref-type="supplementary-material">S2 Table</xref>. The quality scores ranged from 7 to 9 with an average score of 8, indicating that all the cohort studies are of high quality.</p>
<table-wrap id="pone.0134088.t001" position="float">
<object-id pub-id-type="doi">10.1371/journal.pone.0134088.t001</object-id>
<label>Table 1</label> <caption><title>Main characteristics of cohort studies included in the meta-analysis.</title> <p>MI: myocardial infarction, AMI: acute myocardial infarction, PC: prospective cohort, RC: retrospective cohort, NA: not available, CABG: coronary artery bypass graft, ECG: electrocardiogram.</p></caption>
<alternatives>
<graphic id="pone.0134088.t001g" position="float" mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0134088.t001" xlink:type="simple"/>
<table>
<colgroup span="1">
<col align="left" valign="middle" span="1"/>
<col align="left" valign="middle" span="1"/>
<col align="left" valign="middle" span="1"/>
<col align="left" valign="middle" span="1"/>
<col align="left" valign="middle" span="1"/>
<col align="left" valign="middle" span="1"/>
<col align="left" valign="middle" span="1"/>
<col align="left" valign="middle" span="1"/>
<col align="left" valign="middle" span="1"/>
<col align="left" valign="middle" span="1"/>
<col align="left" valign="middle" span="1"/>
<col align="left" valign="middle" span="1"/>
<col align="left" valign="middle" span="1"/>
</colgroup>
<thead>
<tr>
<th align="left" rowspan="1" colspan="1">Author/year</th>
<th align="left" rowspan="1" colspan="1">Category</th>
<th align="left" rowspan="1" colspan="1">Area</th>
<th align="left" rowspan="1" colspan="1">Age (mean), years</th>
<th align="left" rowspan="1" colspan="1">Man, %</th>
<th align="left" rowspan="1" colspan="1">Quality</th>
<th align="left" rowspan="1" colspan="1">Study size</th>
<th align="left" rowspan="1" colspan="1">Gout</th>
<th align="left" rowspan="1" colspan="1">MI</th>
<th align="left" rowspan="1" colspan="1">Follow up, years</th>
<th align="left" rowspan="1" colspan="1">Study design</th>
<th align="left" rowspan="1" colspan="1">Definition of gout</th>
<th align="left" rowspan="1" colspan="1">Assessment of MI</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" rowspan="1" colspan="1">Krishnan/2006 [<xref rid="pone.0134088.ref013" ref-type="bibr">13</xref>]</td>
<td align="left" rowspan="1" colspan="1">NA</td>
<td align="left" rowspan="1" colspan="1">USA</td>
<td align="left" rowspan="1" colspan="1">Gout 47 Not gout 46</td>
<td align="left" rowspan="1" colspan="1">100</td>
<td align="left" rowspan="1" colspan="1">9</td>
<td align="left" rowspan="1" colspan="1">12,866</td>
<td align="left" rowspan="1" colspan="1">1123</td>
<td align="left" rowspan="1" colspan="1">1108</td>
<td align="left" rowspan="1" colspan="1">6.5</td>
<td align="left" rowspan="1" colspan="1">PC</td>
<td align="left" rowspan="1" colspan="1">Self-report+documentation</td>
<td align="left" rowspan="1" colspan="1">Physician evaluations, hospital records, EKGs, and CABG surgery.</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Choi/2007 [<xref rid="pone.0134088.ref014" ref-type="bibr">14</xref>]</td>
<td align="left" rowspan="1" colspan="1">Confirmed</td>
<td align="left" rowspan="1" colspan="1">Canada</td>
<td align="left" rowspan="1" colspan="1">Gout 59 Not gout 54</td>
<td align="left" rowspan="1" colspan="1">100</td>
<td align="left" rowspan="1" colspan="1">8</td>
<td align="left" rowspan="1" colspan="1">1175</td>
<td align="left" rowspan="1" colspan="1">23</td>
<td align="left" rowspan="1" colspan="1">NA</td>
<td align="left" rowspan="1" colspan="1">12</td>
<td align="left" rowspan="1" colspan="1">PC</td>
<td align="left" rowspan="1" colspan="1">American College of Rheumatology survey criteria</td>
<td align="left" rowspan="1" colspan="1">Questionnaires and medical record</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Choi/2007 [<xref rid="pone.0134088.ref014" ref-type="bibr">14</xref>]</td>
<td align="left" rowspan="1" colspan="1">Self-reported</td>
<td align="left" rowspan="1" colspan="1">Canada</td>
<td align="left" rowspan="1" colspan="1">Gout 59 Not gout 54</td>
<td align="left" rowspan="1" colspan="1">100</td>
<td align="left" rowspan="1" colspan="1">7</td>
<td align="left" rowspan="1" colspan="1">1175</td>
<td align="left" rowspan="1" colspan="1">53</td>
<td align="left" rowspan="1" colspan="1">NA</td>
<td align="left" rowspan="1" colspan="1">12</td>
<td align="left" rowspan="1" colspan="1">PC</td>
<td align="left" rowspan="1" colspan="1">Self-reported</td>
<td align="left" rowspan="1" colspan="1">Questionnaires and medical record</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">DeVera/2010 [<xref rid="pone.0134088.ref015" ref-type="bibr">15</xref>]</td>
<td align="left" rowspan="1" colspan="1">Men</td>
<td align="left" rowspan="1" colspan="1">Canada</td>
<td align="left" rowspan="1" colspan="1">Gout 73.9 Not gout 73.3</td>
<td align="left" rowspan="1" colspan="1">100</td>
<td align="left" rowspan="1" colspan="1">8</td>
<td align="left" rowspan="1" colspan="1">34512</td>
<td align="left" rowspan="1" colspan="1">5752</td>
<td align="left" rowspan="1" colspan="1">2272</td>
<td align="left" rowspan="1" colspan="1">7</td>
<td align="left" rowspan="1" colspan="1">RC</td>
<td align="left" rowspan="1" colspan="1">ICD-9</td>
<td align="left" rowspan="1" colspan="1">ICD-9</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">De Vera/2010 [<xref rid="pone.0134088.ref015" ref-type="bibr">15</xref>]</td>
<td align="left" rowspan="1" colspan="1">Women</td>
<td align="left" rowspan="1" colspan="1">Canada</td>
<td align="left" rowspan="1" colspan="1">Gout 75.0 Not gout 75.0</td>
<td align="left" rowspan="1" colspan="1">0</td>
<td align="left" rowspan="1" colspan="1">8</td>
<td align="left" rowspan="1" colspan="1">23340</td>
<td align="left" rowspan="1" colspan="1">3890</td>
<td align="left" rowspan="1" colspan="1">996</td>
<td align="left" rowspan="1" colspan="1">7</td>
<td align="left" rowspan="1" colspan="1">RC</td>
<td align="left" rowspan="1" colspan="1">ICD-9</td>
<td align="left" rowspan="1" colspan="1">ICD-9</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Kuo/2013 [<xref rid="pone.0134088.ref016" ref-type="bibr">16</xref>]</td>
<td align="left" rowspan="1" colspan="1">Men</td>
<td align="left" rowspan="1" colspan="1">China</td>
<td align="left" rowspan="1" colspan="1">NA</td>
<td align="left" rowspan="1" colspan="1">100</td>
<td align="left" rowspan="1" colspan="1">8</td>
<td align="left" rowspan="1" colspan="1">360432</td>
<td align="left" rowspan="1" colspan="1">18674</td>
<td align="left" rowspan="1" colspan="1">2636</td>
<td align="left" rowspan="1" colspan="1">8</td>
<td align="left" rowspan="1" colspan="1">RC</td>
<td align="left" rowspan="1" colspan="1">ICD-9</td>
<td align="left" rowspan="1" colspan="1">ICD-9</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Kuo/2013 [<xref rid="pone.0134088.ref016" ref-type="bibr">16</xref>]</td>
<td align="left" rowspan="1" colspan="1">Women</td>
<td align="left" rowspan="1" colspan="1">China</td>
<td align="left" rowspan="1" colspan="1">NA</td>
<td align="left" rowspan="1" colspan="1">0</td>
<td align="left" rowspan="1" colspan="1">8</td>
<td align="left" rowspan="1" colspan="1">344071</td>
<td align="left" rowspan="1" colspan="1">7882</td>
<td align="left" rowspan="1" colspan="1">1082</td>
<td align="left" rowspan="1" colspan="1">8</td>
<td align="left" rowspan="1" colspan="1">RC</td>
<td align="left" rowspan="1" colspan="1">ICD-9</td>
<td align="left" rowspan="1" colspan="1">ICD-9</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Seminog/2013 [<xref rid="pone.0134088.ref017" ref-type="bibr">17</xref>]</td>
<td align="left" rowspan="1" colspan="1">England</td>
<td align="left" rowspan="1" colspan="1">UK</td>
<td align="left" rowspan="1" colspan="1">NA</td>
<td align="left" rowspan="1" colspan="1">74</td>
<td align="left" rowspan="1" colspan="1">7</td>
<td align="left" rowspan="1" colspan="1">7357019</td>
<td align="left" rowspan="1" colspan="1">202033</td>
<td align="left" rowspan="1" colspan="1">10995</td>
<td align="left" rowspan="1" colspan="1">3.8</td>
<td align="left" rowspan="1" colspan="1">RC</td>
<td align="left" rowspan="1" colspan="1">ICD-7,8,9,10</td>
<td align="left" rowspan="1" colspan="1">ICD-10</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Seminog/2013 [<xref rid="pone.0134088.ref017" ref-type="bibr">17</xref>]</td>
<td align="left" rowspan="1" colspan="1">ORLS</td>
<td align="left" rowspan="1" colspan="1">UK</td>
<td align="left" rowspan="1" colspan="1">NA</td>
<td align="left" rowspan="1" colspan="1">73</td>
<td align="left" rowspan="1" colspan="1">8</td>
<td align="left" rowspan="1" colspan="1">521823</td>
<td align="left" rowspan="1" colspan="1">3174</td>
<td align="left" rowspan="1" colspan="1">89</td>
<td align="left" rowspan="1" colspan="1">5.7</td>
<td align="left" rowspan="1" colspan="1">RC</td>
<td align="left" rowspan="1" colspan="1">ICD-7,8,9,10</td>
<td align="left" rowspan="1" colspan="1">ICD-10</td>
</tr>
</tbody>
</table>
</alternatives>
</table-wrap>
</sec>
<sec id="sec014">
<title>Meta-analysis</title>
<sec id="sec015">
<title>Gout and risk of MI</title>
<p><xref rid="pone.0134088.g002" ref-type="fig">Fig 2</xref> shows the pooled results from the random-effects model that combined the multivariable-adjusted RRs for MI. A total of 8,656,413 participants were included in the analysis (242,604 cases with gout versus 8,413,809 cases without gout). Patients with gout had an increased risk of MI (RR 1.45; 95% CI, 1.19–1.75; <italic>p</italic> &lt;0.001), and significant heterogeneity was observed (<italic>I</italic><sup><italic>2</italic></sup> = 96.1%; <italic>p</italic> &lt;0.001).</p>
<fig id="pone.0134088.g002" position="float">
<object-id pub-id-type="doi">10.1371/journal.pone.0134088.g002</object-id>
<label>Fig 2</label>
<caption>
<title>Forest plot showing the risk of myocardial infarction in patients with gout.</title>
</caption>
<graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0134088.g002" position="float" xlink:type="simple"/>
</fig>
<p>Because of variations between studies with respect to use of the categories of MI, age and sex used in risk reporting, it was impossible to combine all five included studies and calculate a summary RR for each category.</p>
</sec>
<sec id="sec016">
<title>Stratified analyses</title>
<p>The multivariable-adjusted RRs of combined appropriate studies for both fatal MI and non-fatal MI are shown in <xref rid="pone.0134088.g003" ref-type="fig">Fig 3</xref>. The pooled estimates of multivariable-adjusted RRs identified an apparent increased risk of non-fatal MI in gout patients (RR 1.29; 95% CI, 1.19–1.39; <italic>p</italic> &lt;0.001); however, we found no significant association between gout and risk of fatal MI (RR 1.11; 95% CI, 0.96–1.28; <italic>p</italic> = 0.174). We additionally performed a stratified analysis according to gender among patients with gout; the pooled estimated of multivariable-adjusted RRs for the risk of MI were (RR 1.62; 95% CI, 1.18–2.21; <italic>p</italic> = 0.003) for female patients with gout and (RR 1.45; 95% CI, 1.21–1.74; <italic>p</italic> &lt;0.001) for male patients, respectively (<xref rid="pone.0134088.g004" ref-type="fig">Fig 4</xref>).</p>
<fig id="pone.0134088.g003" position="float">
<object-id pub-id-type="doi">10.1371/journal.pone.0134088.g003</object-id>
<label>Fig 3</label>
<caption>
<title>Meta-analysis of the association between gout and different kinds of myocardial infarction (MI; fatal MI and non-fatal MI).</title>
</caption>
<graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0134088.g003" position="float" xlink:type="simple"/>
</fig>
<fig id="pone.0134088.g004" position="float">
<object-id pub-id-type="doi">10.1371/journal.pone.0134088.g004</object-id>
<label>Fig 4</label>
<caption>
<title>Meta-analysis of the association between gout and risk of myocardial infarction in women and men.</title>
</caption>
<graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0134088.g004" position="float" xlink:type="simple"/>
</fig>
<p>Through a comparison of individuals with and without gout in each age group, we observed a gradual increase in MI risk with a younger age at gout onset. As shown in <xref rid="pone.0134088.g005" ref-type="fig">Fig 5</xref>, the pooled results demonstrated this graduated relationship: in the 20–44 years age group (RR 2.82; 95% CI, 1.38–5.79; <italic>p</italic> = 0.05); in the 45–69 years age group (RR 1.85; 95% CI, 1.22–2.82; <italic>p</italic> = 0.04); and in the ≥70 years age group (RR 1.52; 95% CI, 1.22–1.88; <italic>p</italic> &lt;0.001).</p>
<fig id="pone.0134088.g005" position="float">
<object-id pub-id-type="doi">10.1371/journal.pone.0134088.g005</object-id>
<label>Fig 5</label>
<caption>
<title>Meta-analysis of the association between gout and risk of myocardial infarction in age groups.</title>
</caption>
<graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0134088.g005" position="float" xlink:type="simple"/>
</fig>
</sec>
</sec>
</sec>
<sec id="sec017" sec-type="conclusions">
<title>Discussion</title>
<sec id="sec018">
<title>Main findings</title>
<p>To the best of our knowledge, this is the first systematic review and meta-analysis to investigate the association between gout and the risk of MI. The pooled results of five cohort studies suggest that both male and female patients with gout have an increased risk of non-fatal MI, but not of fatal MI. Furthermore, stratified analyses revealed a gradient of increased MI risk with a younger age at gout onset.</p>
</sec>
<sec id="sec019">
<title>Possible mechanisms</title>
<p>Although our meta-analysis indicated that patients with gout have an increased risk of MI, the underlying mechanism remains unclear and there are several possible mechanisms might explain the observed association. Hyperuricemia, which causes gout pathogenesis, and uric acid, which perpetrates hyperuricemia, have been found to associate with cardiovascular disease (CVD).</p>
<p>The inflammatory response associated with gout is characterized simultaneously by the initiation of an acute attack and other typical complex interactions between various cell types [<xref rid="pone.0134088.ref025" ref-type="bibr">25</xref>]. Inflammation associated with gout may play an important role in the initiation and progression of atherosclerosis, as well as in plaque disruption and thrombotic complications, and the various triggers, amplifiers and innate and adaptive immune responses in the cascade of inflammatory events that promotes atherogenesis and thrombogenesis in correlation with CVD. And inflammation also has a long-term prognostic value because inflammation after CVD is associated with an increased risk of recurrent coronary events [<xref rid="pone.0134088.ref026" ref-type="bibr">26</xref>–<xref rid="pone.0134088.ref031" ref-type="bibr">31</xref>]. Therefore, the complex mechanisms of inflammation in patients with gout may lead to an increased risk of CVD.</p>
<p>Hyperuricemia is known to associate with various risk factors of cardiac disease, such as hypertension and obesity; these are also associated with the activation of circulating platelets and microvascular changes potentially reflective of endothelial dysfunction, which, as a precursor, may be an important contributor to the increased risk of CVD [<xref rid="pone.0134088.ref032" ref-type="bibr">32</xref>–<xref rid="pone.0134088.ref035" ref-type="bibr">35</xref>]. Correspondingly, recent studies, including a meta-analysis found that hyperuricemia increased the risk of coronary heart disease [<xref rid="pone.0134088.ref036" ref-type="bibr">36</xref>, <xref rid="pone.0134088.ref037" ref-type="bibr">37</xref>]. Although the association between uric acid and CVD has been recognized for more than a century, it has been rediscovered and appreciated over the past 60 years, during which many epidemiologic studies were performed, most of these studies suggested that increased uric acid levels associate significantly with the risk of CVD [<xref rid="pone.0134088.ref038" ref-type="bibr">38</xref>–<xref rid="pone.0134088.ref043" ref-type="bibr">43</xref>]. Furthermore, several lines of experiments have produced evidence consistent with the results of epidemiological studies; specifically that uric acid is not an inert molecule but rather a deleterious factor that contributes greatly to the development of CVD [<xref rid="pone.0134088.ref044" ref-type="bibr">44</xref>–<xref rid="pone.0134088.ref046" ref-type="bibr">46</xref>]. In addition, uric acid appears to potentially induce persistent systemic and vascular inflammation, as well as vascular mechanisms that might contribute to the progression of atherosclerotic changes and stimulate prothrombotic activity; additionally, uric acid also influences the nitric oxide production, elevates blood pressure, and leads to endothelial dysfunction, potentially also increasing the risk of atherosclerosis [<xref rid="pone.0134088.ref033" ref-type="bibr">33</xref>, <xref rid="pone.0134088.ref047" ref-type="bibr">47</xref>–<xref rid="pone.0134088.ref053" ref-type="bibr">53</xref>]. Uric acid, hyperuricemia and gout are normally observed with other risk factors that promote the occurrence of MI or CVD, and therefore the possible mechanism by which gout affects the risk of MI remains unclear.</p>
</sec>
<sec id="sec020">
<title>Clinical implications</title>
<p>To some extent, the findings from our meta-analysis of previous studies are clinically significant. Despite significant heterogeneity, all of the consistent evidence revealed an increased risk of MI in patients with gout. However, gout was only found to associate with non-fatal MI, but not fatal MI; this might largely be because of mortality was not attributable to the fatal MI events, which were excluded from the analysis, or because a lower incidence of these events was observed [<xref rid="pone.0134088.ref016" ref-type="bibr">16</xref>]. However, a recently published study that explored the risk of mortality from fatal MI in patients with gout also reported no relationship between gout and fatal MI [<xref rid="pone.0134088.ref054" ref-type="bibr">54</xref>]. The reason for this lack of association is also unclear and it might be attributable to classification bias and/or surveillance bias. Interestingly, neither study found an association between gout and risk of suffering from fatal MI or mortality from fatal MI, we believe this is well worth further exploration.</p>
<p>Gender-related differences in the association between gout and MI remain poorly understood. As gout predominantly affects men, and only a handful of studies have included women, and there remains controversy about the strength of gender-related associations [<xref rid="pone.0134088.ref015" ref-type="bibr">15</xref>–<xref rid="pone.0134088.ref017" ref-type="bibr">17</xref>, <xref rid="pone.0134088.ref055" ref-type="bibr">55</xref>]. This controversy might result from differences in uric acid levels associated with physiological function, age, natural menopause and other baseline characteristics of the study cohorts [<xref rid="pone.0134088.ref056" ref-type="bibr">56</xref>]. However, the pooled results suggest that gout is associated with an increased risk of MI in both women and men. Interestingly, the result of our age groups analysis revealed an MI risk gradient that increased MI risk with a younger age at gout onset; in other words, the risk of MI was higher among young patients than older patients, and this finding was somewhat contradictory to the common theory that young people lack traditional CVD or MI risk factors. Although the reason for this phenomenon is unclear, the results of our meta-analysis suggest that these young patients with gout might have other confounding metabolic or vascular risk factors, although these potential factors were seldom observed or unknown; therefore, preventive management and monitoring of MI should be emphasized for all patients diagnosed with gout regardless of age.</p>
</sec>
<sec id="sec021">
<title>Limitations</title>
<p>This study has several important potential limitations inherent to the meta-analytic design. The crucial limitation of our study is the observational nature of the investigations, which might introduces bias from various sources, as well as confounding from other risk factors that could provide an alternative explanation for the significant association observed between gout and the risk of MI. However, allowing for the impossibility of a randomized controlled trial, the included cohort studies had an average NOS of 8, which might reduces the likelihood of recall bias. Admittedly, the NOS has a low inter-reviewer reliability, therefore, the quality appraisal should be performed by at least two reviewers to reduce assessment bias [<xref rid="pone.0134088.ref057" ref-type="bibr">57</xref>].</p>
<p>Second, our meta-analysis contained significant heterogeneity across studies in terms of the study design, follow-up duration, definition of gout, assessment of MI, as well as inconsistent adjustment for vascular risk factors in the multivariate analyses, which might have led to confounding bias; furthermore, inaccurate classification bias might also led to heterogeneity. Furthermore, the confidence intervals for the analysis of fatal MI were very wide, suggesting a possible association between gout and fatal MI that was simply not observed in this dataset, and additional studies will be needed to clarify this phenomenon. Other potential sources of bias are mainly attributable to the nature of data; most studies used data was from various healthcare databases, which usually lack modifying factors.</p>
<p>A third limitation is that there only five articles were confirmed and available for inclusion in this study, rendering the results prone to influence from publication bias or random error, and lacking sufficient reliability to draw a conclusion in a definitive manner.</p>
<p>Finally, although we searched without language restriction and used a comprehensive search strategy, some studies published in other journals or with negative findings might not appear in international journal databases and thus might not have been included in our meta-analysis.</p>
</sec>
</sec>
<sec id="sec022" sec-type="conclusions">
<title>Conclusions</title>
<p>In conclusion, the results of this meta-analysis of five studies indicated that both male and female patients with gout have an increased risk of MI; however, this association remains with non-fatal MI, but not with fatal MI. Additionally, MI risk was found to increase in a gradient with a younger age at gout onset. Nevertheless, these results should be interpreted with caution, given the potential bias and confounding in the included studies.</p>
</sec>
<sec id="sec023">
<title>Supporting Information</title>
<supplementary-material id="pone.0134088.s001" xlink:href="info:doi/10.1371/journal.pone.0134088.s001" mimetype="application/msword" position="float" xlink:type="simple">
<label>S1 PRISMA Checklist</label>
<caption>
<title>PRISMA 2009 checklist used in this meta-analysis.</title>
<p>(DOC)</p>
</caption>
</supplementary-material>
<supplementary-material id="pone.0134088.s002" xlink:href="info:doi/10.1371/journal.pone.0134088.s002" mimetype="application/msword" position="float" xlink:type="simple">
<label>S1 Table</label>
<caption>
<title>The covariates for adjustment in each study.</title>
<p>(DOC)</p>
</caption>
</supplementary-material>
<supplementary-material id="pone.0134088.s003" xlink:href="info:doi/10.1371/journal.pone.0134088.s003" mimetype="application/msword" position="float" xlink:type="simple">
<label>S2 Table</label>
<caption>
<title>The Newcastle-Ottawa Scale (NOS) for assessing the methodological quality of included studies.</title>
<p>(DOC)</p>
</caption>
</supplementary-material>
</sec>
</body>
<back>
<ref-list>
<title>References</title>
<ref id="pone.0134088.ref001"><label>1</label><mixed-citation publication-type="other" xlink:type="simple">WHO. (Updated May 2014) World Health Organization: the 10 leading causes of death by broad income group. Available: <ext-link ext-link-type="uri" xlink:href="http://www.Who.Int/mediacentre/factsheets/fs310/en/" xlink:type="simple">http://www.Who.Int/mediacentre/factsheets/fs310/en/</ext-link> [Accessed July 2015]</mixed-citation></ref>
<ref id="pone.0134088.ref002"><label>2</label><mixed-citation publication-type="book" xlink:type="simple"><collab xlink:type="simple">WHO</collab>. (<year>2008</year>) <chapter-title>The global burden of disease</chapter-title>: 2004 update. <publisher-loc>Geneva, Switzerland</publisher-loc>: <publisher-name>WHO</publisher-name>.</mixed-citation></ref>
<ref id="pone.0134088.ref003"><label>3</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Go</surname> <given-names>AS</given-names></name>, <name name-style="western"><surname>Mozaffarian</surname> <given-names>D</given-names></name>, <name name-style="western"><surname>Roger</surname> <given-names>VL</given-names></name>, <name name-style="western"><surname>Benjamin</surname> <given-names>EJ</given-names></name>, <name name-style="western"><surname>Berry</surname> <given-names>JD</given-names></name>, <name name-style="western"><surname>Borden</surname> <given-names>WB</given-names></name>, <etal>et al</etal>. (<year>2013</year>) <article-title>Heart disease and stroke statistics—2013 update: a report from the American Heart Association</article-title>. <source>Circulation</source> <volume>127</volume>:<fpage>e6</fpage>–<lpage>e245</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1161/CIR.0b013e31828124ad" xlink:type="simple">10.1161/CIR.0b013e31828124ad</ext-link></comment> <object-id pub-id-type="pmid">23239837</object-id></mixed-citation></ref>
<ref id="pone.0134088.ref004"><label>4</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Xu</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Kochanek</surname> <given-names>KD</given-names></name>, <name name-style="western"><surname>Murphy</surname> <given-names>SL</given-names></name>, <name name-style="western"><surname>Tejada-Vera</surname> <given-names>B</given-names></name>. (<year>2010</year>) <article-title>Deaths: final data for 2007</article-title>. <source>Natl Vital Stat Rep</source> <volume>58</volume>:<fpage>1</fpage>–<lpage>19</lpage>.</mixed-citation></ref>
<ref id="pone.0134088.ref005"><label>5</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Annemans</surname> <given-names>L</given-names></name>, <name name-style="western"><surname>Spaepen</surname> <given-names>E</given-names></name>, <name name-style="western"><surname>Gaskin</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Bonnemaire</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Malier</surname> <given-names>V</given-names></name>, <name name-style="western"><surname>Gilbert</surname> <given-names>T</given-names></name>, <etal>et al</etal>. (<year>2008</year>) <article-title>Gout in the UK and Germany: prevalence, comorbidities and management in general practice 2000–2005</article-title>. <source>Ann Rheum Dis</source> <volume>67</volume>:<fpage>960</fpage>–<lpage>966</lpage>. <object-id pub-id-type="pmid">17981913</object-id></mixed-citation></ref>
<ref id="pone.0134088.ref006"><label>6</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Bardin</surname> <given-names>T.</given-names></name>, <name name-style="western"><surname>Bouée</surname> <given-names>S.</given-names></name>, <name name-style="western"><surname>Clerson</surname> <given-names>P.</given-names></name>, <name name-style="western"><surname>Chalès</surname> <given-names>G.</given-names></name>, <name name-style="western"><surname>Doherty</surname> <given-names>M.</given-names></name>, <name name-style="western"><surname>Flipo</surname> <given-names>R.-M.</given-names></name>, <etal>et al</etal>. (<year>2014</year>) <article-title>SAT0544 Prevalence of Gout in the Adult Population of France in 2013</article-title>. <source>Ann Rheum Dis</source> <volume>73</volume>:<fpage>787</fpage>–<lpage>788</lpage></mixed-citation></ref>
<ref id="pone.0134088.ref007"><label>7</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Zhu</surname> <given-names>Y</given-names></name>, <name name-style="western"><surname>Pandya</surname> <given-names>BJ</given-names></name>, <name name-style="western"><surname>Choi</surname> <given-names>HK</given-names></name>. (<year>2011</year>) <article-title>Prevalence of gout and hyperuricemia in the US general population: the National Health and Nutrition Examination Survey 2007–2008</article-title>. <source>Arthritis Rheum</source> <volume>63</volume>:<fpage>3136</fpage>–<lpage>3141</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1002/art.30520" xlink:type="simple">10.1002/art.30520</ext-link></comment> <object-id pub-id-type="pmid">21800283</object-id></mixed-citation></ref>
<ref id="pone.0134088.ref008"><label>8</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Arromdee</surname> <given-names>E</given-names></name>, <name name-style="western"><surname>Michet</surname> <given-names>CJ</given-names></name>, <name name-style="western"><surname>Crowson</surname> <given-names>CS</given-names></name>, <name name-style="western"><surname>O'Fallon</surname> <given-names>WM</given-names></name>, <name name-style="western"><surname>Gabriel</surname> <given-names>SE</given-names></name>. (<year>2002</year>) <article-title>Epidemiology of gout: is the incidence rising?</article-title> <source>J Rheumatol</source> <volume>29</volume>:<fpage>2403</fpage>–<lpage>2406</lpage>. <object-id pub-id-type="pmid">12415600</object-id></mixed-citation></ref>
<ref id="pone.0134088.ref009"><label>9</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Roddy</surname> <given-names>E</given-names></name>, <name name-style="western"><surname>Zhang</surname> <given-names>W</given-names></name>, <name name-style="western"><surname>Doherty</surname> <given-names>M</given-names></name>. (<year>2007</year>) <article-title>The changing epidemiology of gout</article-title>. <source>Nat Clin Pract Rheumatol</source> <volume>3</volume>:<fpage>443</fpage>–<lpage>449</lpage>. <object-id pub-id-type="pmid">17664951</object-id></mixed-citation></ref>
<ref id="pone.0134088.ref010"><label>10</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Weaver</surname> <given-names>AL</given-names></name>. (<year>2008</year>) <article-title>Epidemiology of gout</article-title>. <source>Cleve Clin J Med</source> <volume>75</volume>:<fpage>S9</fpage>–<lpage>12</lpage>. <object-id pub-id-type="pmid">18819329</object-id></mixed-citation></ref>
<ref id="pone.0134088.ref011"><label>11</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Libby</surname> <given-names>P</given-names></name>, <name name-style="western"><surname>Theroux</surname> <given-names>P</given-names></name>. (<year>2005</year>) <article-title>Pathophysiology of coronary artery disease</article-title>. <source>Circulation</source> <volume>111</volume>:<fpage>3481</fpage>–<lpage>3488</lpage>. <object-id pub-id-type="pmid">15983262</object-id></mixed-citation></ref>
<ref id="pone.0134088.ref012"><label>12</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Tiong</surname> <given-names>AY</given-names></name>, <name name-style="western"><surname>Brieger</surname> <given-names>D</given-names></name>. (<year>2005</year>) <article-title>Inflammation and coronary artery disease</article-title>. <source>Am Heart J</source> <volume>150</volume>:<fpage>11</fpage>–<lpage>18</lpage>. <object-id pub-id-type="pmid">16084145</object-id></mixed-citation></ref>
<ref id="pone.0134088.ref013"><label>13</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Krishnan</surname> <given-names>E</given-names></name>, <name name-style="western"><surname>Baker</surname> <given-names>JF</given-names></name>, <name name-style="western"><surname>Furst</surname> <given-names>DE</given-names></name>, <name name-style="western"><surname>Schumacher</surname> <given-names>HR</given-names></name>. (<year>2006</year>) <article-title>Gout and the risk of acute myocardial infarction</article-title>. <source>Arthritis Rheum</source>.<volume>54</volume>:<fpage>2688</fpage>–<lpage>2696</lpage>. <object-id pub-id-type="pmid">16871533</object-id></mixed-citation></ref>
<ref id="pone.0134088.ref014"><label>14</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Choi</surname> <given-names>HK</given-names></name>, <name name-style="western"><surname>Curhan</surname> <given-names>G</given-names></name>. (<year>2007</year>) <article-title>Independent impact of gout on mortality and risk for coronary heart disease</article-title>. <source>Circulation</source> <volume>116</volume>:<fpage>894</fpage>–<lpage>900</lpage>. <object-id pub-id-type="pmid">17698728</object-id></mixed-citation></ref>
<ref id="pone.0134088.ref015"><label>15</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>De Vera</surname> <given-names>MA</given-names></name>, <name name-style="western"><surname>Rahman</surname> <given-names>MM</given-names></name>, <name name-style="western"><surname>Bhole</surname> <given-names>V</given-names></name>, <name name-style="western"><surname>Kopec</surname> <given-names>JA</given-names></name>, <name name-style="western"><surname>Choi</surname> <given-names>HK</given-names></name>. (<year>2010</year>) <article-title>Independent impact of gout on the risk of acute myocardial infarction among elderly women: a population-based study</article-title>. <source>Ann Rheum Dis</source> <volume>69</volume>:<fpage>1162</fpage>–<lpage>1164</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1136/ard.2009.122770" xlink:type="simple">10.1136/ard.2009.122770</ext-link></comment> <object-id pub-id-type="pmid">20124358</object-id></mixed-citation></ref>
<ref id="pone.0134088.ref016"><label>16</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Kuo</surname> <given-names>CF</given-names></name>, <name name-style="western"><surname>Yu</surname> <given-names>KH</given-names></name>, <name name-style="western"><surname>See</surname> <given-names>LC</given-names></name>, <name name-style="western"><surname>Chou</surname> <given-names>IJ</given-names></name>, <name name-style="western"><surname>Ko</surname> <given-names>YS</given-names></name>, <name name-style="western"><surname>Chang</surname> <given-names>HC</given-names></name>, <etal>et al</etal>. (<year>2013</year>) <article-title>Risk of myocardial infarction among patients with gout: a nationwide population-based study</article-title>. <source>Rheumatology (Oxford)</source> <volume>52</volume>:<fpage>111</fpage>–<lpage>117</lpage>.</mixed-citation></ref>
<ref id="pone.0134088.ref017"><label>17</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Seminog</surname> <given-names>OO</given-names></name>, <name name-style="western"><surname>Goldacre</surname> <given-names>MJ</given-names></name>. (<year>2013</year>) <article-title>Gout as a risk factor for myocardial infarction and stroke in England: evidence from record linkage studies</article-title>. <source>Rheumatology (Oxford)</source> <volume>52</volume>:<fpage>2251</fpage>–<lpage>2259</lpage>.</mixed-citation></ref>
<ref id="pone.0134088.ref018"><label>18</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>So</surname> <given-names>A</given-names></name>. (<year>2010</year>) <article-title>Epidemiology: Gout—bad for the heart as well as the joint</article-title>. <source>Nat Rev Rheumatol</source> <volume>6</volume>:<fpage>386</fpage>–<lpage>387</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1038/nrrheum.2010.78" xlink:type="simple">10.1038/nrrheum.2010.78</ext-link></comment> <object-id pub-id-type="pmid">20596050</object-id></mixed-citation></ref>
<ref id="pone.0134088.ref019"><label>19</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Zhu</surname> <given-names>Y</given-names></name>, <name name-style="western"><surname>Pandya</surname> <given-names>BJ</given-names></name>, <name name-style="western"><surname>Choi</surname> <given-names>HK</given-names></name>. (<year>2012</year>) <article-title>Comorbidities of gout and hyperuricemia in the US general population: NHANES 2007–2008</article-title>. <source>Am J Med</source> <volume>125</volume>:<fpage>679</fpage>–<lpage>687.e1</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.amjmed.2011.09.033" xlink:type="simple">10.1016/j.amjmed.2011.09.033</ext-link></comment> <object-id pub-id-type="pmid">22626509</object-id></mixed-citation></ref>
<ref id="pone.0134088.ref020"><label>20</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Stroup</surname> <given-names>DF</given-names></name>, <name name-style="western"><surname>Berlin</surname> <given-names>JA</given-names></name>, <name name-style="western"><surname>Morton</surname> <given-names>SC</given-names></name>, <name name-style="western"><surname>Olkin</surname> <given-names>I</given-names></name>, <name name-style="western"><surname>Williamson</surname> <given-names>GD</given-names></name>, <name name-style="western"><surname>Rennie</surname> <given-names>D</given-names></name>, <etal>et al</etal>. (<year>2000</year>) <article-title>Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group</article-title>. <source>JAMA</source> <volume>283</volume>:<fpage>2008</fpage>–<lpage>2012</lpage>. <object-id pub-id-type="pmid">10789670</object-id></mixed-citation></ref>
<ref id="pone.0134088.ref021"><label>21</label><mixed-citation publication-type="other" xlink:type="simple">GA Wells, B Shea, D O'Connell, J Peterson, V Welch, M Losos, et al. (2013) The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. Available: <ext-link ext-link-type="uri" xlink:href="http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp" xlink:type="simple">www.ohri.ca/programs/clinical_epidemiology/oxford.asp</ext-link>. [Accessed July 2015]</mixed-citation></ref>
<ref id="pone.0134088.ref022"><label>22</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Begg</surname> <given-names>CB</given-names></name>, <name name-style="western"><surname>Mazumdar</surname> <given-names>M</given-names></name>. (<year>1994</year>) <article-title>Operating characteristics of a rank correlation test for publication bias</article-title>. <source>Biometrics</source>. <volume>50</volume>:<fpage>1088</fpage>–<lpage>1101</lpage>. <object-id pub-id-type="pmid">7786990</object-id></mixed-citation></ref>
<ref id="pone.0134088.ref023"><label>23</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>DerSimonian</surname> <given-names>R</given-names></name>, <name name-style="western"><surname>Laird</surname> <given-names>N</given-names></name>. (<year>1986</year>) <article-title>Meta-analysis in clinical trials</article-title>. <source>Control Clin Trials</source> <volume>7</volume>:<fpage>177</fpage>–<lpage>88</lpage>. <object-id pub-id-type="pmid">3802833</object-id></mixed-citation></ref>
<ref id="pone.0134088.ref024"><label>24</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Higgins</surname> <given-names>JP</given-names></name>, <name name-style="western"><surname>Thompson</surname> <given-names>SG</given-names></name>, <name name-style="western"><surname>Deeks</surname> <given-names>JJ</given-names></name>, <name name-style="western"><surname>Altman</surname> <given-names>DG</given-names></name>. (<year>2003</year>) <article-title>Measuring inconsistency in meta-analyses</article-title>. <source>BMJ</source> <volume>327</volume>:<fpage>557</fpage>–<lpage>560</lpage>. <object-id pub-id-type="pmid">12958120</object-id></mixed-citation></ref>
<ref id="pone.0134088.ref025"><label>25</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Dalbeth</surname> <given-names>N</given-names></name>, <name name-style="western"><surname>Haskard</surname> <given-names>DO</given-names></name>. (<year>2005</year>) <article-title>Mechanisms of inflammation in gout</article-title>. <source>Rheumatology (Oxford)</source> <volume>44</volume>:<fpage>1090</fpage>–<lpage>1096</lpage>.</mixed-citation></ref>
<ref id="pone.0134088.ref026"><label>26</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Tiong</surname> <given-names>AY</given-names></name>, <name name-style="western"><surname>Brieger</surname> <given-names>D</given-names></name>. (<year>2005</year>) <article-title>Inflammation and coronary artery disease</article-title>. <source>Am Heart J</source> <volume>150</volume>:<fpage>11</fpage>–<lpage>18</lpage>. <object-id pub-id-type="pmid">16084145</object-id></mixed-citation></ref>
<ref id="pone.0134088.ref027"><label>27</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Pascual</surname> <given-names>E</given-names></name>. (<year>1991</year>) <article-title>Persistence of monosodium urate crystals and low-grade inflammation in the synovial fluid of patients with untreated gout</article-title>. <source>Arthritis Rheum</source> <volume>34</volume>:<fpage>141</fpage>–<lpage>145</lpage>. <object-id pub-id-type="pmid">1994910</object-id></mixed-citation></ref>
<ref id="pone.0134088.ref028"><label>28</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Dalbeth</surname> <given-names>N</given-names></name>, <name name-style="western"><surname>Haskard</surname> <given-names>DO</given-names></name>. (<year>2005</year>) <article-title>Mechanisms of inflammation in gout</article-title>. <source>Rheumatology (Oxford)</source> <volume>44</volume>:<fpage>1090</fpage>–<lpage>1096</lpage>.</mixed-citation></ref>
<ref id="pone.0134088.ref029"><label>29</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Krishnan</surname> <given-names>E</given-names></name>, <name name-style="western"><surname>Svendsen</surname> <given-names>K</given-names></name>, <name name-style="western"><surname>Neaton</surname> <given-names>JD</given-names></name>, <name name-style="western"><surname>Grandits</surname> <given-names>G</given-names></name>, <name name-style="western"><surname>Kuller</surname> <given-names>LH</given-names></name>. (<year>2008</year>) <article-title>Long-term cardiovascular mortality among middle-aged men with gout</article-title>. <source>Arch Intern Med</source> <volume>168</volume>:<fpage>1104</fpage>–<lpage>1110</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1001/archinte.168.10.1104" xlink:type="simple">10.1001/archinte.168.10.1104</ext-link></comment> <object-id pub-id-type="pmid">18504339</object-id></mixed-citation></ref>
<ref id="pone.0134088.ref030"><label>30</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Busso</surname> <given-names>N</given-names></name>, <name name-style="western"><surname>So</surname> <given-names>A</given-names></name>. (<year>2010</year>) <article-title>Mechanisms of inflammation in gout</article-title>. <source>Arthritis Res Ther</source> <volume>12</volume>:<fpage>206</fpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1186/ar2952" xlink:type="simple">10.1186/ar2952</ext-link></comment> <object-id pub-id-type="pmid">20441605</object-id></mixed-citation></ref>
<ref id="pone.0134088.ref031"><label>31</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Edwards</surname> <given-names>NL</given-names></name>. (<year>2008</year>) <article-title>The role of hyperuricemia and gout in kidney and cardiovascular disease</article-title>. <source>Cleve Clin J Med</source> <volume>75</volume>:<fpage>S13</fpage>–<lpage>16</lpage>.</mixed-citation></ref>
<ref id="pone.0134088.ref032"><label>32</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Ballocca</surname> <given-names>F</given-names></name>, <name name-style="western"><surname>D'Ascenzo</surname> <given-names>F</given-names></name>, <name name-style="western"><surname>Moretti</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Omedè</surname> <given-names>P</given-names></name>, <name name-style="western"><surname>Cerrato</surname> <given-names>E</given-names></name>, <name name-style="western"><surname>Barbero</surname> <given-names>U</given-names></name>, <etal>et al</etal>. (<year>2014</year>) <article-title>Predictors of cardiovascular events in patients with systemic lupus erythematosus (SLE): a systematic review and meta-analysis</article-title>. <source>Eur J Prev Cardiol</source> [Epub ahead of print]</mixed-citation></ref>
<ref id="pone.0134088.ref033"><label>33</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Johnson</surname> <given-names>RJ</given-names></name>, <name name-style="western"><surname>Kang</surname> <given-names>DH</given-names></name>, <name name-style="western"><surname>Feig</surname> <given-names>D</given-names></name>, <name name-style="western"><surname>Kivlighn</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Kanellis</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Watanabe</surname> <given-names>S</given-names></name>, <etal>et al</etal>. (<year>2003</year>) <article-title>Is there a pathogenetic role for uric acid in hypertension and cardiovascular and renal disease?</article-title> <source>Hypertension</source> <volume>41</volume>:<fpage>1183</fpage>–<lpage>1190</lpage>. <object-id pub-id-type="pmid">12707287</object-id></mixed-citation></ref>
<ref id="pone.0134088.ref034"><label>34</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Becker</surname> <given-names>MA</given-names></name>, <name name-style="western"><surname>Jolly</surname> <given-names>M</given-names></name>. (<year>2006</year>) <article-title>Hyperuricemia and associated diseases</article-title>. <source>Rheum Dis Clin North Am</source> <volume>32</volume>:<fpage>275</fpage>–<lpage>93</lpage>, v-vi. <object-id pub-id-type="pmid">16716880</object-id></mixed-citation></ref>
<ref id="pone.0134088.ref035"><label>35</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Halligan</surname> <given-names>C</given-names></name>; <name name-style="western"><surname>Matteson</surname> <given-names>EL</given-names></name>. (<year>2005</year>) <article-title>Hyperuricemia and coronary artery disease</article-title>. <source>Current Rheumatology Reviews</source> <volume>1</volume>:<fpage>193</fpage>–<lpage>197</lpage>.</mixed-citation></ref>
<ref id="pone.0134088.ref036"><label>36</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Brodov</surname> <given-names>Y</given-names></name>, <name name-style="western"><surname>Behar</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Boyko</surname> <given-names>V</given-names></name>, <name name-style="western"><surname>Chouraqui</surname> <given-names>P</given-names></name>. (<year>2010</year>) <article-title>Effect of the metabolic syndrome and hyperuricemia on outcome in patients with coronary artery disease (from the Bezafibrate Infarction Prevention Study)</article-title>. <source>Am J Cardiol</source> <volume>106</volume>:<fpage>1717</fpage>–<lpage>1720</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.amjcard.2010.07.046" xlink:type="simple">10.1016/j.amjcard.2010.07.046</ext-link></comment> <object-id pub-id-type="pmid">21126615</object-id></mixed-citation></ref>
<ref id="pone.0134088.ref037"><label>37</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Kim</surname> <given-names>SY</given-names></name>, <name name-style="western"><surname>Guevara</surname> <given-names>JP</given-names></name>, <name name-style="western"><surname>Kim</surname> <given-names>KM</given-names></name>, <name name-style="western"><surname>Choi</surname> <given-names>HK</given-names></name>, <name name-style="western"><surname>Heitjan</surname> <given-names>DF</given-names></name>, <name name-style="western"><surname>Albert</surname> <given-names>DA</given-names></name>. (<year>2010</year>) <article-title>Hyperuricemia and coronary heart disease: a systematic review and meta-analysis</article-title>. <source>Arthritis Care Res (Hoboken)</source>. <volume>62</volume>:<fpage>170</fpage>–<lpage>180</lpage>.</mixed-citation></ref>
<ref id="pone.0134088.ref038"><label>38</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Fang</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Alderman</surname> <given-names>MH</given-names></name>. (<year>2000</year>) <article-title>Serum uric acid and cardiovascular mortality the NHANES I epidemiologic follow-up study, 1971–1992. National Health and Nutrition Examination Survey</article-title>. <source>JAMA</source> <volume>283</volume>:<fpage>2404</fpage>–<lpage>2410</lpage>. <object-id pub-id-type="pmid">10815083</object-id></mixed-citation></ref>
<ref id="pone.0134088.ref039"><label>39</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Niskanen</surname> <given-names>LK</given-names></name>, <name name-style="western"><surname>Laaksonen</surname> <given-names>DE</given-names></name>, <name name-style="western"><surname>Nyyssönen</surname> <given-names>K</given-names></name>, <name name-style="western"><surname>Alfthan</surname> <given-names>G</given-names></name>, <name name-style="western"><surname>Lakka</surname> <given-names>HM</given-names></name>, <name name-style="western"><surname>Lakka</surname> <given-names>TA</given-names></name>, <etal>et al</etal>. (<year>2004</year>) <article-title>Uric acid level as a risk factor for cardiovascular and all-cause mortality in middle-aged men: a prospective cohort study</article-title>. <source>Arch Intern Med</source> <volume>164</volume>:<fpage>1546</fpage>–<lpage>1551</lpage>. <object-id pub-id-type="pmid">15277287</object-id></mixed-citation></ref>
<ref id="pone.0134088.ref040"><label>40</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Freedman</surname> <given-names>DS</given-names></name>, <name name-style="western"><surname>Williamson</surname> <given-names>DF</given-names></name>, <name name-style="western"><surname>Gunter</surname> <given-names>EW</given-names></name>, <name name-style="western"><surname>Byers</surname> <given-names>T</given-names></name>. (<year>1995</year>) <article-title>Relation of serum uric acid to mortality and ischemic heart disease. The NHANES I Epidemiologic Follow-up Study</article-title>. <source>Am J Epidemiol</source> <volume>141</volume>:<fpage>637</fpage>–<lpage>644</lpage>. <object-id pub-id-type="pmid">7702038</object-id></mixed-citation></ref>
<ref id="pone.0134088.ref041"><label>41</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Verdecchia</surname> <given-names>P</given-names></name>, <name name-style="western"><surname>Schillaci</surname> <given-names>G</given-names></name>, <name name-style="western"><surname>Reboldi</surname> <given-names>G</given-names></name>, <name name-style="western"><surname>Santeusanio</surname> <given-names>F</given-names></name>, <name name-style="western"><surname>Porcellati</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Brunetti</surname> <given-names>P</given-names></name>. (<year>2000</year>) <article-title>Relation between serum uric acid and risk of cardiovascular disease in essential hypertension. The PIUMA study</article-title>. <source>Hypertension</source> <volume>36</volume>:<fpage>1072</fpage>–<lpage>1078</lpage>. <object-id pub-id-type="pmid">11116127</object-id></mixed-citation></ref>
<ref id="pone.0134088.ref042"><label>42</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Lee</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Sparrow</surname> <given-names>D</given-names></name>, <name name-style="western"><surname>Vokonas</surname> <given-names>PS</given-names></name>, <name name-style="western"><surname>Landsberg</surname> <given-names>L</given-names></name>, <name name-style="western"><surname>Weiss</surname> <given-names>ST</given-names></name>. (<year>1995</year>) <article-title>Uric acid and coronary heart disease risk: evidence for a role of uric acid in the obesity-insulin resistance syndrome. The Normative Aging Study</article-title>. <source>Am J Epidemiol</source> <volume>142</volume>:<fpage>288</fpage>–<lpage>294</lpage>. <object-id pub-id-type="pmid">7631632</object-id></mixed-citation></ref>
<ref id="pone.0134088.ref043"><label>43</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Feig</surname> <given-names>DI</given-names></name>, <name name-style="western"><surname>Kang</surname> <given-names>DH</given-names></name>, <name name-style="western"><surname>Johnson</surname> <given-names>RJ</given-names></name>. (<year>2008</year>) <article-title>Uric acid and cardiovascular risk</article-title>. <source>N Engl J Med</source> <volume>359</volume>:<fpage>1811</fpage>–<lpage>1121</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1056/NEJMra0800885" xlink:type="simple">10.1056/NEJMra0800885</ext-link></comment> <object-id pub-id-type="pmid">18946066</object-id></mixed-citation></ref>
<ref id="pone.0134088.ref044"><label>44</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Mazzali</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Hughes</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Kim</surname> <given-names>YG</given-names></name>, <name name-style="western"><surname>Jefferson</surname> <given-names>JA</given-names></name>, <name name-style="western"><surname>Kang</surname> <given-names>DH</given-names></name>, <name name-style="western"><surname>Gordon</surname> <given-names>KL</given-names></name>, <etal>et al</etal>. (<year>2001</year>) <article-title>Elevated uric acid increases blood pressure in the rat by a novel crystal-independent mechanism</article-title>. <source>Hypertension</source> <volume>38</volume>:<fpage>1101</fpage>–<lpage>1106</lpage>. <object-id pub-id-type="pmid">11711505</object-id></mixed-citation></ref>
<ref id="pone.0134088.ref045"><label>45</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Sánchez-Lozada</surname> <given-names>LG</given-names></name>, <name name-style="western"><surname>Tapia</surname> <given-names>E</given-names></name>, <name name-style="western"><surname>Avila-Casado</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Soto</surname> <given-names>V</given-names></name>, <name name-style="western"><surname>Franco</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Santamaría</surname> <given-names>J</given-names></name>, <etal>et al</etal>. (<year>2002</year>) <article-title>Mild hyperuricemia induces glomerular hypertension in normal rats</article-title>. <source>Am J Physiol Renal Physiol</source> <volume>283</volume>: <fpage>F1105</fpage>–<lpage>1110</lpage>. <object-id pub-id-type="pmid">12372787</object-id></mixed-citation></ref>
<ref id="pone.0134088.ref046"><label>46</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Sánchez-Lozada</surname> <given-names>LG</given-names></name>, <name name-style="western"><surname>Tapia</surname> <given-names>E</given-names></name>, <name name-style="western"><surname>Santamaría</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Avila-Casado</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Soto</surname> <given-names>V</given-names></name>, <name name-style="western"><surname>Nepomuceno</surname> <given-names>T</given-names></name>, <etal>et al</etal>. (<year>2005</year>) <article-title>Mild hyperuricemia induces vasoconstriction and maintains glomerular hypertension in normal and remnant kidney rats</article-title>. <source>Kidney Int</source> <volume>67</volume>:<fpage>237</fpage>–<lpage>247</lpage>. <object-id pub-id-type="pmid">15610247</object-id></mixed-citation></ref>
<ref id="pone.0134088.ref047"><label>47</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Libby</surname> <given-names>P</given-names></name>, <name name-style="western"><surname>Ridker</surname> <given-names>PM</given-names></name>, <name name-style="western"><surname>Maseri</surname> <given-names>A</given-names></name>. <article-title>Inflammation and atherosclerosis</article-title>. (<year>2002</year>) <source>Circulation</source> <volume>105</volume>:<fpage>1135</fpage>–<lpage>1143</lpage>. <object-id pub-id-type="pmid">11877368</object-id></mixed-citation></ref>
<ref id="pone.0134088.ref048"><label>48</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Kanellis</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Watanabe</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Li</surname> <given-names>JH</given-names></name>, <name name-style="western"><surname>Kang</surname> <given-names>DH</given-names></name>, <name name-style="western"><surname>Li</surname> <given-names>P</given-names></name>, <name name-style="western"><surname>Nakagawa</surname> <given-names>T</given-names></name>, <etal>et al</etal>. (<year>2003</year>) <article-title>Uric acid stimulates monocyte chemoattractant protein-1 production in vascular smooth muscle cells via mitogen-activated protein kinase and cyclooxygenase-2</article-title>. <source>Hypertension</source> <volume>41</volume>:<fpage>1287</fpage>–<lpage>1293</lpage>. <object-id pub-id-type="pmid">12743010</object-id></mixed-citation></ref>
<ref id="pone.0134088.ref049"><label>49</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Netea</surname> <given-names>MG</given-names></name> <name name-style="western"><surname>Kullberg</surname> <given-names>BJ</given-names></name>, <name name-style="western"><surname>Blok</surname> <given-names>WL</given-names></name>, <name name-style="western"><surname>Netea</surname> <given-names>RT</given-names></name>, <name name-style="western"><surname>van der Meer</surname> <given-names>JW</given-names></name>. (<year>1997</year>) <article-title>The role of hyperuricemia in the increased cytokine production after lipopolysaccharide challenge in neutropenic mice</article-title>. <source>Blood</source> <volume>89</volume>:<fpage>577</fpage>–<lpage>582</lpage>. <object-id pub-id-type="pmid">9002961</object-id></mixed-citation></ref>
<ref id="pone.0134088.ref050"><label>50</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Mazzali</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Hughes</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Kim</surname> <given-names>YG</given-names></name>, <name name-style="western"><surname>Jefferson</surname> <given-names>JA</given-names></name>, <name name-style="western"><surname>Kang</surname> <given-names>DH</given-names></name>, <name name-style="western"><surname>Gordon</surname> <given-names>KL</given-names></name>, <etal>et al</etal>. (<year>2001</year>) <article-title>Elevated uric acid increases blood pressure in the rat by a novel crystal-independent mechanism</article-title>. <source>Hypertension</source> <volume>38</volume>:<fpage>1101</fpage>–<lpage>1106</lpage>. <object-id pub-id-type="pmid">11711505</object-id></mixed-citation></ref>
<ref id="pone.0134088.ref051"><label>51</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Kanellis</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Kang</surname> <given-names>DH</given-names></name>. (<year>2005</year>) <article-title>Uric acid as a mediator of endothelial dysfunction, inflammation, and vascular disease</article-title>. <source>Semin Nephrol</source> <volume>25</volume>:<fpage>39</fpage>–<lpage>42</lpage>. <object-id pub-id-type="pmid">15660333</object-id></mixed-citation></ref>
<ref id="pone.0134088.ref052"><label>52</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Gersch</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Palii</surname> <given-names>SP</given-names></name>, <name name-style="western"><surname>Kim</surname> <given-names>KM</given-names></name>, <name name-style="western"><surname>Angerhofer</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Johnson</surname> <given-names>RJ</given-names></name>, <name name-style="western"><surname>Henderson</surname> <given-names>GN</given-names></name>. <article-title>Inactivation of nitric oxide by uric acid</article-title>. <source>Nucleosides Nucleotides Nucleic Acids</source> <volume>27</volume>:<fpage>967</fpage>–<lpage>978</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1080/15257770802257952" xlink:type="simple">10.1080/15257770802257952</ext-link></comment> <object-id pub-id-type="pmid">18696365</object-id></mixed-citation></ref>
<ref id="pone.0134088.ref053"><label>53</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Gür</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Sahin</surname> <given-names>DY</given-names></name>, <name name-style="western"><surname>Elbasan</surname> <given-names>Z</given-names></name>, <name name-style="western"><surname>Kalkan</surname> <given-names>GY</given-names></name>, <name name-style="western"><surname>Yıldız</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Kaya</surname> <given-names>Z</given-names></name>, <etal>et al</etal>. (<year>2013</year>) <article-title>Uric acid and high sensitive C-reactive protein are associated with subclinical thoracic aortic atherosclerosis</article-title>. <source>J Cardiol</source> <volume>61</volume>:<fpage>144</fpage>–<lpage>148</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.jjcc.2012.08.023" xlink:type="simple">10.1016/j.jjcc.2012.08.023</ext-link></comment> <object-id pub-id-type="pmid">23159203</object-id></mixed-citation></ref>
<ref id="pone.0134088.ref054"><label>54</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Clarson</surname> <given-names>LE</given-names></name>, <name name-style="western"><surname>Chandratre</surname> <given-names>P</given-names></name>, <name name-style="western"><surname>Hider</surname> <given-names>SL</given-names></name>, <name name-style="western"><surname>Belcher</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Heneghan</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Roddy</surname> <given-names>E</given-names></name>, <etal>et al</etal>. (<year>2015</year>) <article-title>Increased cardiovascular mortality associated with gout: a systematic review and meta-analysis</article-title>. <source>Eur J Prev Cardiol</source> <volume>22</volume>:<fpage>335</fpage>–<lpage>343</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1177/2047487313514895" xlink:type="simple">10.1177/2047487313514895</ext-link></comment> <object-id pub-id-type="pmid">24281251</object-id></mixed-citation></ref>
<ref id="pone.0134088.ref055"><label>55</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Kuo</surname> <given-names>CF</given-names></name>, <name name-style="western"><surname>See</surname> <given-names>LC</given-names></name>, <name name-style="western"><surname>Luo</surname> <given-names>SF</given-names></name>, <name name-style="western"><surname>Ko</surname> <given-names>YS</given-names></name>, <name name-style="western"><surname>Lin</surname> <given-names>YS</given-names></name>, <name name-style="western"><surname>Hwang</surname> <given-names>JS</given-names></name>, <etal>et al</etal>. (<year>2010</year>) <article-title>Gout: an independent risk factor for all-cause and cardiovascular mortality</article-title>. <source>Rheumatology (Oxford)</source> <volume>49</volume>:<fpage>141</fpage>–<lpage>146</lpage>.</mixed-citation></ref>
<ref id="pone.0134088.ref056"><label>56</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Puig</surname> <given-names>JG</given-names></name>, <name name-style="western"><surname>Michán</surname> <given-names>AD</given-names></name>, <name name-style="western"><surname>Jiménez</surname> <given-names>ML</given-names></name>, <name name-style="western"><surname>Pérez de Ayala</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Mateos</surname> <given-names>F</given-names></name>. (<year>1991</year>) <article-title>Female gout. Clinical spectrum and uric acid metabolism</article-title>. <source>Arch Intern Med</source> <volume>151</volume>:<fpage>726</fpage>–<lpage>732</lpage>. <object-id pub-id-type="pmid">2012455</object-id></mixed-citation></ref>
<ref id="pone.0134088.ref057"><label>57</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Hartling</surname> <given-names>L</given-names></name>, <name name-style="western"><surname>Milne</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Hamm</surname> <given-names>MP</given-names></name>, <name name-style="western"><surname>Vandermeer</surname> <given-names>B</given-names></name>, <name name-style="western"><surname>Ansari</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Tsertsvadze</surname> <given-names>A</given-names></name>, <etal>et al</etal>. (<year>2013</year>) <article-title>Testing the Newcastle Ottawa Scale showed low reliability between individual reviewers</article-title>. <source>J Clin Epidemiol</source> <volume>66</volume>:<fpage>982</fpage>–<lpage>993</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.jclinepi.2013.03.003" xlink:type="simple">10.1016/j.jclinepi.2013.03.003</ext-link></comment> <object-id pub-id-type="pmid">23683848</object-id></mixed-citation></ref>
</ref-list>
</back>
</article>